Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn’s disease

Author: Sandborn W. J.   Colombel J.-F.   D’Haens G.   Plevy S. E.   Panés J.   Robinson A. M.   Pollack P. F.   Zhou Q.   Castillo M.   Thakkar R. B.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.29, Iss.5, 2013-05, pp. : 483-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content